Stockholders’ Deficit (Details)	1 Months Ended		3 Months Ended		12 Months Ended
	Feb. 29, 2020 USD ($) shares	Jan. 31, 2020 USD ($) $ / shares shares	Mar. 31, 2021 USD ($) $ / shares shares	Mar. 31, 2020 USD ($)	Dec. 31, 2020 USD ($) $ / shares shares	Dec. 31, 2019 USD ($)
Stockholders’ Deficit (Details) [Line Items]
Common stock, shares authorized (in Shares) | shares			500,000,000		500,000,000
preferred stock, shares authorized (in Shares) | shares			2,000,000		2,000,000
Common stock value			$ 2,258,000	$ 1,113,000
Common stock shares (in Shares) | shares		2,010,000
Exercise price per share (in Dollars per Share) | $ / shares		0.07
Price per share (in Dollars per share) | $ / shares			$ 0.32
Shares issued for convertible notes			$ 47,499
Stock issued for restricted stock agreement (in Shares) | shares			31,250
Stock value issued for restricted stock agreement			$ 4,550
Warrant exercise price per share (in Dollars per share) | $ / shares			$ 0.0614		$ 0.0627
Shares of exercise of options (in Shares) | shares			1,005,682
Stock value exercise of options			$ 1,090,910
Options exercise price per share (in Dollars per share) | $ / shares			$ 0.32
Stock based compensation expense			$ 170,029
Reversal of convertible preferred stock dividend accrual			$ 13,602		$ 264,000
Series A convertible preferred stock, liquidation preference (in Dollars per share) | $ / shares			$ 25.00
Series A convertible preferred stock, dividend rate			6.50%
Weighted average of the last sales prices			95.00%
liquidation preference			7.50%
Dividend rate increase			10.00%
Preferred stock conversion price per share (in Dollars per share) | $ / shares			$ 12.00
Stockholders equity, description			If the closing sale price of the common stock is greater than 140% of the conversion price on 20 out of 30 trading days, the company may redeem the Series A Preferred Stock in whole or in part at any time through October 31, 2010, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the shares to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, subject to certain conditions. In addition, beginning November 1, 2010, the company may redeem the Series A Preferred Stock in whole or in part, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the Series A Preferred Stock to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, under certain conditions.
Common stock discount shares description			The purchase price is payable, at the corporation’s option, (x) in cash, (y) in shares of the common stock at a discount of 5% from the fair market value of Common Stock on the Purchase Date (i.e. valued at a 95% discount of the Common Stock on the Purchase Date), or (z) any combination thereof.
Reserved a total possible issuance under the plan (in Shares) | shares			50,000,000
Total stock-based compensation expense for grants			$ 174,579	$ 440,000
Issuable in acquisition, description					As of March 31, 2021 and December 31, 2020 there was $724,750 and $892,000, respectively, in unrecognized stock-based compensation related to a lockup agreement on 5,000,000 shares of common stock in the acquisition of AOS valued at $0.4014 a share as that was the closing price on the date of the contract and is amortized over 36 months. $167,250 and $167,250 was amortized for the three months ended March 31, 2021 and 2020, respectively
unrecognized stock based compensation					$ 892,000	$ 724,750
Minimum [Member]
Stockholders’ Deficit (Details) [Line Items]
Amount of dividend rate increase if distribution not made within five business days following dividend payment date			1.00%
Maximum [Member]
Stockholders’ Deficit (Details) [Line Items]
Amount of dividend rate increase if distribution not made within five business days following dividend payment date			6.50%
Stock option [Member]
Stockholders’ Deficit (Details) [Line Items]
Options exercise price per share (in Dollars per share) | $ / shares			$ 0.05
Share-based compensation, options granted (in Shares) | shares			29,909,090
Share-based compensation, options outstanding, weighted average exercise price (in Dollars per share) | $ / shares			$ 0.1374
Share-based compensation, options outstanding, weighted average remaining contractual term			5 years 146 days
Options outstanding aggregate intrinsic value			$ 19,959,000
Unrecognized compensation costs related to unvested equity awards, net of estimated forfeitures			541,000
Private Placement [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock value			$ 2,258,000
Common Stock [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock value	$ 510,000	$ 603,000
Common stock shares (in Shares) | shares	1,700,000		7,056,250
Issue of warrants (in Shares) | shares		25,000
Stock issued for convertible notes (in Shares) | shares			158,329
Shares issued for convertible notes			$ 47,499
Warrant [Member]
Stockholders’ Deficit (Details) [Line Items]
Stock value issued for exercise of warrants (in Shares) | shares			600,000
Warrant exercise price per share (in Dollars per share) | $ / shares			$ 0.07
Preferred Stock [Member]
Stockholders’ Deficit (Details) [Line Items]
liquidation preference			101.00%